Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne.

Trends in Pharmacological Sciences
B W MetcalfD A Holt

Abstract

Benign prostatic hyperplasia is an androgen-dependent disease which afflicts a large percentage of males over the age of fifty, and is usually treated by surgery. Dihydrotestosterone, a 5 alpha-reduced metabolite of testosterone, has been implicated as a causative factor in the progression of the disease, largely through the clinical study of males who are genetically deficient in the dihydrotestosterone-producing enzyme, steroid 5 alpha-reductase. As a result, inhibition of this enzyme has become a pharmacological strategy for the treatment of benign prostatic hyperplasia as well as other dihydrotestosterone-related disorders such as acne and male pattern baldness. In this review, Brian Metcalf and colleagues focus on the chemical and kinetic mechanisms of steroid 5 alpha-reductase, and known inhibitors of this enzyme, and discuss the rationale behind the design of a mechanistically distinct class of steroid 5 alpha-reductase inhibitors.

References

Jan 1, 1979·Methods in Enzymology·W W Cleland
Feb 1, 1977·The American Journal of Medicine·R E PetersonE Sturla
Apr 1, 1986·Journal of Steroid Biochemistry·J S CampbellH J Karavolas
Jul 20, 1968·Nature·K M Anderson, S Liao
Jan 1, 1982·Proceedings of the Society for Experimental Biology and Medicine·J R BrooksG H Rasmusson
Dec 1, 1982·The Journal of Endocrinology·V PetrowA Tantawi
Nov 1, 1981·European Journal of Biochemistry·E BayerH Eggerer
Jul 16, 1980·Biochemical and Biophysical Research Communications·T R BlohmG L Schatzman
Aug 1, 1953·The Biochemical Journal·M DIXON

❮ Previous
Next ❯

Citations

Jan 1, 1992·International Urology and Nephrology·I FaredinS Scultéty
Jun 1, 1995·Steroids·X LiF ] Labire F [corrected to Labrie
Oct 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·A B OrdmanH Nick
Nov 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·E di SalleA Panzeri
Apr 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·J HirosumiM Okuhara
Feb 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·M A LevyB W Metcalf
Feb 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·E Di SalleA Panzeri
Jun 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·D GiudiciE di Salle
Jul 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·K EllsworthG S Harris
Mar 18, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Ernesto G OcchiatoMario Serio
Apr 16, 2003·Hormones and Behavior·Gabriela González-MariscalJay S Rosenblatt
May 30, 1998·The Journal of Steroid Biochemistry and Molecular Biology·E di SalleP M Martin
Mar 25, 2000·The Journal of Steroid Biochemistry and Molecular Biology·A M McNultyB L Neubauer
Jan 30, 1999·Bioorganic & Medicinal Chemistry·H TakamiT Kumazawa
Jan 13, 1994·The New England Journal of Medicine·R S Rittmaster
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S Andersson, D W Russell
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K S HirschD W Russell
Jul 1, 1992·British Journal of Clinical Pharmacology·M A TouchetteD J Edwards
Feb 8, 2006·Biological & Pharmaceutical Bulletin·Jie LiuRyuichiro Kondo
Jul 18, 2001·Chemical & Pharmaceutical Bulletin·K SawadaH Tanaka
Nov 7, 2002·Chemical & Pharmaceutical Bulletin·Marisa CabezaIvonne Heuze
Dec 6, 2005·Chemical & Pharmaceutical Bulletin·Elena RamírezTeresa Ramírez
Mar 18, 2009·Bioorganic & Medicinal Chemistry Letters·Jie LiuRyuichiro Kondo
May 15, 2007·Bioorganic & Medicinal Chemistry·Jie LiuRyuichiro Kondo
Feb 26, 2009·British Journal of Pharmacology·Patrick W F HadokeBrian R Walker
Feb 24, 2009·Chemistry & Biodiversity·Jie LiuRyuichiro Kondo
Dec 8, 2004·Bioorganic & Medicinal Chemistry Letters·Alessandro FerraliAntonio Guarna
Jul 27, 2001·Best Practice & Research. Clinical Endocrinology & Metabolism·Y Jin, T M Penning
Oct 25, 2006·Journal of Enzyme Inhibition and Medicinal Chemistry·Marisa CabezaIsabel Gracia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.